Press Release Covis Pharma Group Announces Two Executive Management Team Appointments -Appointment of Raghav Chari as Chief Innovation Officer to lead product portfolio lifecycle management. -Appointment of Nicolas Verbeke as Senior Vice President, Europe &...
Press Release Covis Significantly Strengthens Global Respiratory Portfolio Through Acquisition of Two Medicines from AstraZeneca ZUG, SWITZERLAND, November 1, 2021 – Covis Pharma Group (“Covis”), a global specialty pharmaceutical company that markets therapeutic...
Press Release New data in the European Heart Journal show ciraparantag reverses the anticoagulant activity of apixaban and rivaroxaban in elderly patients Zug, Switzerland, October 4, 2021 – Covis Pharma GmbH (“Covis”) and Norgine B.V. (“Norgine”) today announced data...
Press Release Covis Pharma Announces FDA’s Decision to Grant Public Hearing for Only FDA-Approved Treatment to Reduce Preterm Birth in Indicated Patients Zug, Switzerland, August 19, 2021 – Covis Group S.à r.l. (“Covis”) announced today that the U.S. Food and...
Press Release COVIS PHARMA GROUP Announces Top-line Safety and Efficacy Data from a Phase 3 Placebo Controlled COVID-19 Study Using Inhaled Corticosteroid (ciclesonide) Zug, Switzerland, April 15, 2021 – Covis Pharma Group (the “Company”), a global specialty...
Press Release EPPPIC Study Reaffirms 17-OHPC for Reducing Early Preterm Birth in High-Risk, Singleton Pregnancies LUXEMBOURG and ZUG, Switzerland – March 26, 2021 – Covis Group S.à r.l. (“Covis”) announced today that the updated results of EPPPIC (Evaluating...